SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-002152
Filing Date
2022-01-14
Accepted
2022-01-14 16:28:56
Documents
15
Period of Report
2022-01-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154019-8k_revelation.htm   iXBRL 8-K 105728
2 LIST OF SUBSIDIARIES. ea154019ex21-1_revelation.htm EX-21.1 1881
3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AS O ea154019ex99-1_revelation.htm EX-99.1 138976
  Complete submission text file 0001213900-22-002152.txt   507541

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE revb-20220110.xsd EX-101.SCH 4187
5 XBRL DEFINITION FILE revb-20220110_def.xml EX-101.DEF 27327
6 XBRL LABEL FILE revb-20220110_lab.xml EX-101.LAB 37865
7 XBRL PRESENTATION FILE revb-20220110_pre.xml EX-101.PRE 25941
9 EXTRACTED XBRL INSTANCE DOCUMENT ea154019-8k_revelation_htm.xml XML 7242
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 22532166
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences